I admit...I admit that I am apprehensive about the future... but I can tell you definitively that I have no plans to sell. In fact, I have never written a single SELL ticket on Prometic (although I have certainly wished I had on occasion, I once had a healthy low six digit profit on paper )
As ugly as things look right now, I do honestly believe the risk reward is actually quite favourable. In fact, I quite firmly believe that we will at least double from these levels in six months or less... and I will re-evaluate at that time...
I think we all get a little caught up in the cash crunch. While there is no question the dilution SUKS... If the programs the dilution funds have paybacks that are a multiple of the relative dilution... then we will go up... simple. ie: Should the company have a $200mm market cap if its proven to have a successful Phase 2 anemia drug AND a share in the worlds only proven and accepted BSE blood filter technology ? I guess I feel that I have seen valuations much higher... for a lot less underlying value... As frustrating as this journey has been... you have to truly try and see thru the day to day shrapnel.
Think about this... even with 200mm shares outstanding...at $2/share we are only a $400mm market cap company (roughly) .... How hard would it be to justify that with a couple of the key value drivers in place ? I think the smart money stays long from here to at least see a few shoes drop.... although I admit it will be really ugly if it all starts unravelling... I just think the risk reward still largely favours the better case scenario.